1.Date the punishment was imposed: May 1, 2018
2.Recipient of the punishment: Responsible person Chang OO of Medigen Biotechnology Corp. (TPEX-listed company, Code 3176, hereinafter referred to as “Medigen Biotechnology”). 
3.Legal basis of the punishment: Article 36-1 of the Securities and Exchange Act and paragraph 3, Article 7 of the Regulations Governing the Acquisition and Disposal of Assets by Public Companies. 
4.Facts of the violation and reasons: Medigen Biotechnology failed to ensure that TBG Diagnostics Limited, its subsidiary, had, in accordance with the relevant regulations, established and implemented its internal procedures governing the acquisition and disposal of assets before executing the related transactions. This constitutes a violation of the aforementioned regulations.
5.The disciplinary action: Pursuant to sub-paragraph 7, paragraph 1, Article 178 and paragraph 1, Article 179 of the Securities and Exchange Act, an administrative fine of NTD240,000 is imposed on the responsible person of the Company.